These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33415725)

  • 21. Integrity of SARS-CoV-2 Laboratory-Developed Tests.
    Genzen JR; Rychert J; George TI
    JAMA; 2022 Aug; 328(5):478. PubMed ID: 35916853
    [No Abstract]   [Full Text] [Related]  

  • 22. Romeo and Juliet: Revisited (at the time of COVID-19).
    Costantino G; Peyvandi F; Montano N; Agostoni C
    Eur J Intern Med; 2020 Nov; 81():94. PubMed ID: 32653154
    [No Abstract]   [Full Text] [Related]  

  • 23. Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
    Adashi EY; Cohen G
    JAMA; 2022 Aug; 328(5):478-479. PubMed ID: 35916850
    [No Abstract]   [Full Text] [Related]  

  • 24. A word of caution in interpreting COVID-19 diagnostics tests.
    Silva SJRD; Pena LJ
    J Med Virol; 2021 Feb; 93(2):717-718. PubMed ID: 32949173
    [No Abstract]   [Full Text] [Related]  

  • 25. How to establish an academic SARS-CoV-2 testing laboratory.
    Richter A; Plant T; Kidd M; Bosworth A; Mayhew M; Megram O; Ashworth F; Crawford L; White T; Moles-Garcia E; Mirza J; Percival B; McNally A
    Nat Microbiol; 2020 Dec; 5(12):1452-1454. PubMed ID: 33139885
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of three TaqMan real-time reverse transcription-PCR assays in detecting SARS-CoV-2.
    Xiao Y; Li Z; Wang X; Wang Y; Wang Y; Wang G; Ren L; Li J
    J Virol Methods; 2021 Feb; 288():114030. PubMed ID: 33275927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.
    Scheier T; Schibli A; Eich G; Rüegg C; Kube F; Schmid A; Karrer U; Wolfensberger A; Sax H; Schreiber PW
    Emerg Infect Dis; 2021 Feb; 27(2):404-410. PubMed ID: 33395382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 Laboratory Testing/CDC Guidelines.
    McFee DRB
    Dis Mon; 2020 Sep; 66(9):101067. PubMed ID: 32883517
    [No Abstract]   [Full Text] [Related]  

  • 30. Lateral flow tests cannot rule out SARS-CoV-2 infection.
    Deeks JJ; Raffle AE
    BMJ; 2020 Dec; 371():m4787. PubMed ID: 33310701
    [No Abstract]   [Full Text] [Related]  

  • 31. Delays in testing as a source of COVID-19 false-negative results.
    Zimmer R
    Can Fam Physician; 2020 Dec; 66(12):e298-e301. PubMed ID: 33334962
    [No Abstract]   [Full Text] [Related]  

  • 32. [SARS-CoV-2 Testing in Cadavers: The Experience of the Southern Portugal Delegation of the National Institute of Forensic Medicine and Forensic Sciences].
    Logrado D; Inácio AR; Amorim A; Dos Santos C; Cunha E
    Acta Med Port; 2020 Dec; 33(12):858. PubMed ID: 33496257
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
    Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
    Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography-computed tomography use during the COVID-19 pandemic outbreak.
    Goksel S; Rakici SY
    J Cancer Res Ther; 2021; 17(2):574-575. PubMed ID: 34121710
    [No Abstract]   [Full Text] [Related]  

  • 35. Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.
    Gao J; Quan L
    Med Sci Monit; 2020 Dec; 26():e928552. PubMed ID: 33332288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses.
    Barrios LC; Green RF; Honein MA
    J Adolesc Health; 2021 Jan; 68(1):1-2. PubMed ID: 33349351
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
    Graham M; Williams E; Isles N; Buadromo E; Toatu T; Druce J; Catton M; Lin C; Howden BP; Williamson DA
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115238. PubMed ID: 33171384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.